Infinity Pharmaceuticals Inc (INFIQ)
0.0000
USD |
OTCM |
May 03, 14:59
Infinity Pharmaceuticals Net Income (TTM): -40.95M for June 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -40.95M |
| March 31, 2023 | -42.98M |
| December 31, 2022 | -44.37M |
| September 30, 2022 | -46.79M |
| June 30, 2022 | -46.79M |
| March 31, 2022 | -46.07M |
| December 31, 2021 | -45.26M |
| September 30, 2021 | -44.21M |
| June 30, 2021 | -43.03M |
| March 31, 2021 | -41.24M |
| December 31, 2020 | -40.49M |
| September 30, 2020 | -41.28M |
| June 30, 2020 | -43.16M |
| March 31, 2020 | -44.20M |
| December 31, 2019 | -47.06M |
| September 30, 2019 | -43.90M |
| June 30, 2019 | -19.10M |
| March 31, 2019 | -15.55M |
| December 31, 2018 | -11.25M |
| September 30, 2018 | -10.33M |
| June 30, 2018 | -30.81M |
| March 31, 2018 | -40.80M |
| December 31, 2017 | -41.83M |
| September 30, 2017 | -57.46M |
| June 30, 2017 | -69.86M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.088M |
| December 31, 2016 | -30.10M |
| September 30, 2016 | -46.36M |
| June 30, 2016 | 15.68M |
| March 31, 2016 | -75.74M |
| December 31, 2015 | -128.38M |
| September 30, 2015 | -129.53M |
| June 30, 2015 | -68.86M |
| March 31, 2015 | -68.45M |
| December 31, 2014 | -17.42M |
| September 30, 2014 | -9.998M |
| June 30, 2014 | -147.15M |
| March 31, 2014 | -141.72M |
| December 31, 2013 | -126.78M |
| September 30, 2013 | -140.84M |
| June 30, 2013 | -88.50M |
| March 31, 2013 | -70.57M |
| December 31, 2012 | -53.96M |
| September 30, 2012 | -21.04M |
| June 30, 2012 | -51.39M |
| March 31, 2012 | -48.46M |
| December 31, 2011 | -40.04M |
| September 30, 2011 | -40.02M |
| June 30, 2011 | -49.02M |
| March 31, 2011 | -43.24M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-47.06M
Minimum
Dec 2019
-19.10M
Maximum
Jun 2019
-42.40M
Average
-43.90M
Median
Sep 2019
Net Income (TTM) Benchmarks
| Athersys Inc | -37.51M |
| Merck & Co Inc | 2.306B |
| MEI Pharma Inc | 19.84M |
| Humanigen Inc | -53.63M |
| Bristol-Myers Squibb Co | -6.148B |